Skip to content
Economy

BASF Terminates Evonik Acquisition Plans After Rejection Of Two Offers

News Georgia Editorial team · AI-written, reviewed under our editorial standards · · Reading time 7min read · Views 0 ·
Key — BASF terminates acquisition efforts for Evonik after Evonik rejected two non-binding purchase offers.

The German chemical group BASF has formally terminated its acquisition efforts for the specialty chemicals manufacturer Evonik. This decision follows the rejection of two previous non-binding purchase offers made by BASF to the German chemical group Evonik. The termination marks the end of negotiations between the two major chemical entities following a period of intense corporate maneuvering and strategic discussions. BASF stated that pursuing the transaction at a higher price would not be in the best interest of its shareholders.

BASF Final Offer Details

BASF's final offer proposed a price of 24 Euros per Evonik share. This specific offer valued the specialty chemicals manufacturer Evonik at eleven billion Euros. BASF executive Markus Kamieth stated that the 24 Euro offer represented a significant additional and secure value for Evonik shareholders. The German chemical group BASF remains the largest chemical group globally in terms of operational scale and market presence.

The German chemical group Evonik is recognized globally as a specialty chemicals manufacturer operating across various industrial sectors. Evonik's management rejected a substantial exchange proposal from BASF. The management maintained that the risks associated with Evonik operating as an independent company did not justify a higher valuation for the enterprise. Evonik previously communicated in late October that it would not negotiate an acquisition with BASF based on available information at that time.

Market Reaction To Termination

Following the announcement of the termination of acquisition plans, market reactions were immediate across both corporate entities. Evonik shares temporarily dropped by more than 23 percent. The temporary price of Evonik shares fell to 16.75 Euros during the trading session. Conversely, BASF shares rose by up to 2.4 percent following the corporate announcement. These market movements reflected investor sentiment regarding the outcome of the high-stakes corporate transaction.

Future Outlook For Evonik

The board of directors at Evonik expressed strong confidence in the company's future as an independent entity. Markus Kamieth stated that the merger under BASF ownership would create a stronger chemical company offering value to shareholders, employees, and customers. The rejection of the acquisition signals a continued commitment by Evonik leadership to maintaining operational autonomy. The German chemical group Evonik remains focused on its independent strategic objectives moving forward.

Glossary

  • shareholders — Shareholders are individuals who own shares in a company. The text mentions that pursuing a transaction at a higher price would not be in the best interest of its shareholders.
  • Euros — Euros is a currency used in the context of a specific offer price. The text mentions that BASF's final offer proposed a price of 24 Euros per Evonik share.
  • operational autonomy — Operational autonomy refers to the degree of self-governance of a company. The text mentions that the rejection of the acquisition signals a continued commitment by Evonik leadership to maintaining operational autonomy.
  • independent entity — An independent entity is a company that operates separately from other participants. The text mentions that the board of directors at Evonik expressed strong confidence in the company's future as an independent entity.

This article was written with AI assistance from multiple news reports and is reviewed by our editors under our editorial principles. Editorial Standards · Tips & Contact

How did you like this post?

Comments 0

Be the first to comment

Contact us

← News Georgia Home
News Georgia Get new posts by emailSubscribe to receive new content via email. Unsubscribe anytime.
Was this helpful?Share it with friends & social